Abstract

REVIEW: PHARMACOLOGICAL INTERVENTION OF FUNGAL INFECTION

Samiksha R. Onkar*, Aman Bondre, Vishnudas Lokhande, R. S. Bijwar, L. N. Barde

Abstract

The high incidence of fungal infections has become a worrisome public health issue, having been aggravated by an increase in host predisposition factors. Despite all the drugs available on the market to treat these diseases, their efficiency is questionable, and their side effects cannot be neglected. Bearing that in mind, it is of upmost importance to synthetize new and innovative carriers for these medicines not only to fight emerging fungal infections but also to avert the increase in drug-resistant strains. Although it has revealed to be a difficult job, new nano-based drug delivery systems and even new cellular targets and compounds with antifungal potential are now being investigated. This article will provide a summary of the state-of-the-art strategies that have been studied in order to improve antifungal therapy and reduce adverse effects of conventional drugs. The bidirectional relationship between Mycology and Nanotechnology will be also explained. Furthermore, the article will focus on new compounds from the marine environment which have a proven antifungal potential and may act as platforms to discover drug-like characteristics, investigated the challenges of the translation of these natural compounds into the clinical pipeline.

Keywords: Mycology, Nanotechnology, fungal, investigated, investigated, conventional, Therapy.